CI

At a glance

ClinicalIndex Comparison Record
N/AUnknown· 20 target
Drug / intervention
colonic transendoscopic enteral tubingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03949257
NCT03949257N/AUnknown

Dynamic Changes of Gut Microbiota in Patients With Ulcerative Colitis After Fecal Transplantation

The Second Hospital of Nanjing Medical University·interventional·Posted May 14, 2019·Updated May 14, 2019

In Brief

A clinical study evaluating colonic transendoscopic enteral tubing for Ulcerative Colitis. Targeting 20 participants across 1 site.

Detailed Summary

A prospective study to investigate the dynamic changes of gut microbiota through colonic transendoscopic enteral tubing in patients with ulcerative colitis after fecal microbiota transplantation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/AUnknownOverdue
2020202120222023202420252026
First PostedMay 14, 2019
Enrollment StartJun 1, 2019
Primary CompletionSep 1, 2019
Study CompletionDec 1, 2019
TodayJul 1, 2026
Enrollment to primary: 3 monthsPosted 7.1 years ago

Interventions

colonic transendoscopic enteral tubingdevice

Colonic transendoscopic enteral tubing (TET) is a novel, safe, convenient, and reliable way for fecal microbiota transplantation (FMT) and the whole-colon enema treatment.